This site is intended for Healthcare Professionals only.

RPS joins efforts to boost children’s health in Wales


Share post:

A group of 20 royal colleges and professional bodies unite to elevate the profile of child health in Wales 

The Royal Pharmaceutical Society (RPS) has joined the Welsh Royal Colleges Child Health Collaborative (WRCCHC) – a newly established group comprising 20 royal colleges and professional bodies that aims to improve health outcomes for children in Wales.

Together they have written to the First Minister of Wales asking how his government will improve child health and support the workforce that care for them.

Citing recent reports published by the Academy of Medical Royal Colleges and the Academy of Medical Sciences that highlighted declining health among children, they have warned of the impact of poor child health.

The WRCCHC aims to ensure a sharper focus and understanding on the current and necessary support required for babies, children and young people and the workforce they represent.

RPS Wales will be represented in the group by Anthony Lewis, Children and Women Lead Pharmacist at Cardiff and Vale University Health Board.

Anthony believes that this collaboration will improve the profile of child health in Wales.

“Together with the RPS Wales team, I’ll also be highlighting important pharmacy and medicines management priorities such as medicines safety and spreading best practice in medicines support for children like the KidzMedz initiative.

“We will highlight that pharmacy expertise is always part of the team supporting children and their families; from highly specialist care in hospitals to care closer to home in the community,” he said.

RPS Wales Chair, Dr Geraldine McAffrey, expressed confidence that Anthony will ensure that important issues relating to medicines and the specialist paediatric pharmacy workforce receive due attention.


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...